Assessment of best corrected visual acuity in type 2 diabetic patients with meibomian gland dysfunction

Abstract

Introduction: Meibomian gland dysfunction (MGD)is considered an inflammatory state and a trigger for evaporative dry eye disease (DED) (1). Aim of the study: Assessment of visual acuity in patients with MGD including type 2 diabetic patients. Patients and methods: This was a case control study; the study was conducted on 90 eyes of 90 patients with meibomian gland dysfunction were randomly classified into 3 groups, and assessment of visual acuity was done in each group. The study was done in Ophthalmology department, Minia University Hospital, Egypt between December 2022 to May 2023. Results: There was a significant difference between the 3 groups in best corrected visual acuity (BCVA) in patients with meibomian gland dysfunction, more pronounced in patients with Diabetes mellitus (DM). Conclusion: In patients with MGD, BCVA was affected especially in type 2 diabetic patients. Presence of hyperglycemia leads to MGD and causes evaporative dry eye disease, which consequently leads to poor vision.